Kolesar JM - Search Results

1

Macrophage Repolarization as a Therapeutic Strategy for Osteosarcoma.

Anand N, Peh KH, Kolesar JM. Anand N, et al. Among authors: kolesar jm. Int J Mol Sci. 2023 Feb 2;24(3):2858. doi: 10.3390/ijms24032858. Int J Mol Sci. 2023. PMID: 36769180 Free PMC article. Review.

2

Molecular Tumor Board Review and Improved Overall Survival in Non-Small-Cell Lung Cancer.

Huang B, Chen Q, Allison D, El Khouli R, Peh KH, Mobley J, Anderson A, Durbin EB, Goodin D, Villano JL, Miller RW, Arnold SM, Kolesar JM. Huang B, et al. Among authors: kolesar jm. JCO Precis Oncol. 2021 Sep 29;5:PO.21.00210. doi: 10.1200/PO.21.00210. eCollection 2021. JCO Precis Oncol. 2021. PMID: 34622117 Free PMC article.

3

Metabolic Dysregulation Explains the Diverse Impacts of Obesity in Males and Females with Gastrointestinal Cancers.

Rosario SR, Dong B, Zhang Y, Hsiao HH, Isenhart E, Wang J, Siegel EM, Monjazeb AM, Owen DH, Dey P, Tabung FK, Spakowicz DJ, Murphy WJ, Edge S, Yendamuri S, Ibrahimi S, Kolesar JM, McDonald PH, Vadehra D, Churchman M, Liu S, Kalinski P, Mukherjee S. Rosario SR, et al. Among authors: kolesar jm. Int J Mol Sci. 2023 Jun 29;24(13):10847. doi: 10.3390/ijms241310847. Int J Mol Sci. 2023. PMID: 37446025 Free PMC article.

4

SYNE1 Mutation Is Associated with Increased Tumor Mutation Burden and Immune Cell Infiltration in Ovarian Cancer.

Harbin LM, Lin N, Ueland FR, Kolesar JM. Harbin LM, et al. Among authors: kolesar jm. Int J Mol Sci. 2023 Sep 18;24(18):14212. doi: 10.3390/ijms241814212. Int J Mol Sci. 2023. PMID: 37762518 Free PMC article.

5

Macrophage-Engineered Vesicles for Therapeutic Delivery and Bidirectional Reprogramming of Immune Cell Polarization.

Neupane KR, McCorkle JR, Kopper TJ, Lakes JE, Aryal SP, Abdullah M, Snell AA, Gensel JC, Kolesar J, Richards CI. Neupane KR, et al. ACS Omega. 2021 Jan 26;6(5):3847-3857. doi: 10.1021/acsomega.0c05632. eCollection 2021 Feb 9. ACS Omega. 2021. PMID: 33585763 Free PMC article.

6

Integration of liquid biopsy and pharmacogenomics for precision therapy of EGFR mutant and resistant lung cancers.

Kolesar J, Peh S, Thomas L, Baburaj G, Mukherjee N, Kantamneni R, Lewis S, Pai A, Udupa KS, Kumar An N, Rangnekar VM, Rao M. Kolesar J, et al. Mol Cancer. 2022 Feb 24;21(1):61. doi: 10.1186/s12943-022-01534-8. Mol Cancer. 2022. PMID: 35209919 Free PMC article. Review.

7

Defective DNA repair in hereditary ovarian cancers: Implications for therapy.

Burgess BT, Kolesar JM. Burgess BT, et al. Among authors: kolesar jm. Am J Health Syst Pharm. 2018 Nov 1;75(21):1697-1707. doi: 10.2146/ajhp180124. Epub 2018 Sep 18. Am J Health Syst Pharm. 2018. PMID: 30228165 Review.

8

Liquid biopsy approaches for pleural effusion in lung cancer patients.

Baburaj G, Damerla RR, Udupa KS, Parida P, Munisamy M, Kolesar J, Rao M. Baburaj G, et al. Mol Biol Rep. 2020 Oct;47(10):8179-8187. doi: 10.1007/s11033-020-05869-7. Epub 2020 Oct 7. Mol Biol Rep. 2020. PMID: 33029702 Review.

9

Evaluation of Fall and Fracture Risk Among Men With Prostate Cancer Treated With Androgen Receptor Inhibitors: A Systematic Review and Meta-analysis.

Myint ZW, Momo HD, Otto DE, Yan D, Wang P, Kolesar JM. Myint ZW, et al. Among authors: kolesar jm. JAMA Netw Open. 2020 Nov 2;3(11):e2025826. doi: 10.1001/jamanetworkopen.2020.25826. JAMA Netw Open. 2020. PMID: 33201234 Free PMC article.

10

Lapatinib and poziotinib overcome ABCB1-mediated paclitaxel resistance in ovarian cancer.

McCorkle JR, Gorski JW, Liu J, Riggs MB, McDowell AB, Lin N, Wang C, Ueland FR, Kolesar JM. McCorkle JR, et al. Among authors: kolesar jm. PLoS One. 2021 Aug 4;16(8):e0254205. doi: 10.1371/journal.pone.0254205. eCollection 2021. PLoS One. 2021. PMID: 34347777 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

174 results

Search Page